Table 5.

Reports of resource utilization in bleeding patients with IMC

Category	Count	%
Extended LOS	18	100.0%
FFP	12	66.7%
RBC	10	55.6%
Vit K	10	55.6%
Steroids	8	44.4%
PLT	8	44.4%
IVIG	7	38.9%
Plasmapheresis	5	27.8%
Chemotherapy	3	16.7%

LOS – Length of stay; FFP – fresh frozen plasma; Vit K – vitamin K; IVIG – intravenous immune globulin; PLT – platelets; RBC – red blood cells

Interventions among the 18 bleeding patients for whom case reports contained documentation of managing immune-mediated coagulopathy [6,7,9,10,15-17,20,23,26,27,30,31,33,34].